No More Gaslighting About Vaccine Injury
The move earlier this month by the U.S. Department of Health and Human Services (DHHS) to launch a clinical research program and center dedicated to studying “patients experiencing health problems following vaccination” is described as an effort to “to strengthen how the federal government identifies, documents, investigates, and responds to health problems reported following vaccination, […]
NIH to Launch Research Center on Vaccine Injuries
The U.S. National Institutes of Health (NIH) will launch a clinical research program and dedicated center to study individuals who were harmed by vaccines, including COVID-19 shots. Officials at the National Institute of Allergy and Infectious Diseases (NIAID) discussed establishing the research center at the NIH campus in Bethesda, Maryland, with the program potentially beginning […]
Healthy Volunteers in Canada Paid to Be Infected With Influenza in Government-Funded Research
A new study registered with ClinicalTrials.gov is deliberately exposing healthy adults to a live influenza A(H3N2) virus in Canada. Health Canada’s Biologic and Radiopharmaceutical Drugs Directorate has approved the H3N2 challenge strain for use in humans specifically for the purposes of the study. The study is not evaluating a vaccine or other biologic, rather it’s […]
Top Adviser to Anthony Fauci Pleads Guilty to Federal Conspiracy to Hide COVID-19 Research Records
David Morens, MD, a senior adviser to Anthony Fauci, MD at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), pleaded guilty in federal court on Aug. 18, 2026 to one count of conspiracy to commit offenses and to defraud the United States. The charge stems from a scheme to evade Freedom of Information […]
Live Experimental Pneumonic Plague Vaccines Being Developed After Repeated Attempts
University of Texas Medical Branch (UTMB) researchers have developed live attenuated experimental pneumonic plague vaccines that, according to a July 28, 2026 press release, fully protected mice in a preclinical study. The findings were published in Science Translational Medicine and, according to UTMB researchers, “challenge decades of assumptions about how immunity to plague works and […]
FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
Despite a number of significant limitations in the available safety and efficacy data for licensure review of Moderna, Inc.’s new mRNA influenza biologic mFlusiva, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee ((VRBPAC) voted on June 18, 2026 to recommend fast-tracked licensure of the first mRNA product to target […]